Study emphasizes importance of women in cardiac research
Study Findings:
- Women with abnormal heart rhythms benefit from implantable cardioverter defibrillators (ICDs) as much as men.
- An overall benefit from the ICD was observed (45% in men and 53% in women) with no significant influence related to gender.
Method:
- The Multicenter UnSustained Tachycardia Trial (MUSTT) studied the influence of gender in 2,202 patients with coronary artery disease and an abnormal heart pumping function across 85 clinical sites.
“This [study] has implications for the development of future trials and stresses the importance of making every effort to include women,” said Dr. Andrea Russo, lead investigator of MUSTT. “As cardiovascular disease is the leading cause of death in both men and women, this also emphasizes the importance of ensuring that women have access to the ICD, in addition to any other life-saving cardiovascular therapies.”
Related Articles:
- Original Research: Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia Trial
- Press Release
Recent Entries
- Laughing is good for the heart
- Absence of critical protein linked to infertility
- Head and neck cancer research
- Vertebroplasty and fractures
- Smoking while pregnant causes finger, toe deformities
- Dogs can smell early-stage cancer!
- Understanding fatigue in chronic liver disease
- Immune substances may help antibody-based drugs fight cancer
- Asthma txt alerts!
- New depression research